The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity.

摘要: OBJECTIVE The aim: To evaluate the hemodynamic and echocardiographic parameters, level of adiponectin IL-6 in such patients under influence therapy with sartans (telmisartan or olmesartan) atorvastatin 12 weeks later. PATIENTS AND METHODS Materials methods: Fifty arterial hypertension II stage 2 level, who underwent elective in-patient treatment were examined. During next weeks, they took olmesartan (1st group) telmisartan (2nd combination atorvastatin. RESULTS Results: combined use for had a resulted significant decrease systolic diastolic blood pressure, heart rate myocardial mass. After atorvastatin, content increased by 41.6% (p <0.05). In group receiving telmisartan, an increase was noted 80.0% shown significantly higher levels, namely 59.4% after <0.01). has decreased, both administration (2.7 times) (2.6 (p<0.01). CONCLUSION Conclusions: Telmisartan, comparison olmesartan, reduces size left ventricular atrium myocardium, decreased mass index. Telmisartan improves cardio-metabolic profile obese hypertensive concentrations levels.